Holen Sie sich die Stockscreener-App
1.61
9.52%
0.14
Handel nachbörslich:
1.60
-0.01
-0.62%
Schlusskurs vom Vortag:
$1.47
Offen:
$1.5
24-Stunden-Volumen:
1.21M
Relative Volume:
2.32
Marktkapitalisierung:
$99.85M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-73.79M
KGV:
-0.875
EPS:
-1.84
Netto-Cashflow:
$-77.44M
1W Leistung:
+21.05%
1M Leistung:
+46.36%
6M Leistung:
+41.23%
1J Leistung:
-54.13%
1-Tages-Spanne:
$1.43
$1.63
1-Wochen-Bereich:
$1.27
$1.63
52-Wochen-Spanne:
$0.8332
$5.3899
Pyxis Oncology Inc Stock (PYXS) Company Profile
Firmenname
Pyxis Oncology Inc
Sektor
Branche
Telefon
(617) 221-9059
Adresse
321 HARRISON AVENUE, BOSTON
Vergleichen Sie PYXS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PYXS
Pyxis Oncology Inc
|
1.61 | 82.48M | 0 | -73.79M | -77.44M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-21 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-11-08 | Eingeleitet | Stephens | Overweight |
| 2024-08-08 | Eingeleitet | Stifel | Buy |
| 2024-05-07 | Fortgesetzt | Jefferies | Buy |
| 2024-02-09 | Eingeleitet | BTIG Research | Buy |
| 2024-01-23 | Eingeleitet | Leerink Partners | Outperform |
| 2023-09-05 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-11-02 | Eingeleitet | BofA Securities | Neutral |
| 2021-11-02 | Eingeleitet | Credit Suisse | Outperform |
| 2021-11-02 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Pyxis Oncology Inc Aktie (PYXS) Neueste Nachrichten
Will Pyxis Oncology Inc. benefit from macro trendsWeekly Trend Report & Safe Entry Point Identification - Newser
Is Pyxis Oncology Inc. stock entering bullish territoryTrade Risk Summary & Low Drawdown Trading Strategies - Newser
Chart based exit strategy for Pyxis Oncology Inc.2025 Major Catalysts & Weekly High Return Opportunities - Newser
Volatility clustering patterns for Pyxis Oncology Inc.July 2025 Closing Moves & Daily Momentum Trading Reports - Newser
Published on: 2025-09-03 07:15:40 - Newser
Applying big data sentiment scoring on Pyxis Oncology Inc.Weekly Investment Recap & Fast Entry Momentum Trade Alerts - Newser
Best data tools to analyze Pyxis Oncology Inc. stockJuly 2025 Closing Moves & Momentum Based Trading Signals - Newser
What’s the recovery path for long term holders of Pyxis Oncology Inc.Buy Signal & Reliable Price Breakout Signals - Newser
Is Pyxis Oncology Inc. still worth holding after the dipJuly 2025 News Drivers & Daily Profit Maximizing Tips - Newser
Will Pyxis Oncology Inc. stock recover after recent dropWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - Newser
Applying chart zones and confluence areas to Pyxis Oncology Inc.July 2025 Momentum & Short-Term Swing Trade Alerts - Newser
Is it too late to sell Pyxis Oncology Inc.Entry Point & Weekly Breakout Opportunity Watchlist - Newser
Has Pyxis Oncology Inc. formed a bullish divergenceLong Setup & Risk Adjusted Swing Trade Ideas - Newser
What is the long term forecast for Pyxis Oncology Inc. stockJuly 2025 News Drivers & AI Powered Trade Plan Recommendations - khodrobank.com
Forecasting Pyxis Oncology Inc. price range with options dataQuarterly Portfolio Summary & Free Real-Time Volume Trigger Notifications - Newser
Can technical indicators confirm Pyxis Oncology Inc.’s reversalMarket Growth Summary & Risk Managed Trade Strategies - Newser
How to integrate Pyxis Oncology Inc. into portfolio analysis tools2025 Performance Recap & Free Technical Confirmation Trade Alerts - Newser
Using data models to predict Pyxis Oncology Inc. stock movementPortfolio Return Report & Low Drawdown Trading Techniques - Newser
Visual analytics tools that track Pyxis Oncology Inc. performanceTrade Risk Report & Safe Entry Trade Signal Reports - Newser
Is Pyxis Oncology Inc. stock risky to hold nowPortfolio Value Report & AI Powered Market Entry Strategies - kpenews.com
Heatmap analysis for Pyxis Oncology Inc. and competitorsTrade Analysis Report & Community Consensus Trade Alerts - Newser
What MACD signals say about Pyxis Oncology Inc.2025 Growth vs Value & Consistent Income Trade Recommendations - Newser
Moving Average Crossover Confirms Uptrend in Pyxis Oncology Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Can Pyxis Oncology Inc. recover in the next quarterEarnings Performance Report & Real-Time Stock Entry Alerts - Newser
Long term hold vs stop loss in Pyxis Oncology Inc.2025 Trade Ideas & Scalable Portfolio Growth Ideas - Newser
Pyxis Oncology Inc. stock chart pattern explainedSell Signal & Growth Focused Entry Reports - Newser
Finanzdaten der Pyxis Oncology Inc-Aktie (PYXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):